The role of DC-STAMP in maintenance of immune tolerance through regulation of dendritic cell function
Yumi Sawatani(Kumamoto University), Toshio Suda(Chinese Academy of Sciences), Jun Imai(Takasaki University of Health and Welfare), Mikako Maruya(RIKEN Center for Integrative Medical Sciences), Masanori Shinohara(Kumamoto University), Nobuyuki Fujita(Fujita Health University), Shigenori Nagai(Tohoku University), Shigeo Koyasu(National Institutes for Quantum Science and Technology), Ken Ninomiya(Kawasaki Hospital), T. Suzuki, Yoshiaki Toyama(Keio University), Takeshi Miyamoto(Kumamoto Health Science University), Ryotaro Iwasaki(Keio University), Kana Miyamoto(Kumamoto University)
Cited by 39
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694